Latest & greatest articles for obesity

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on obesity or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on obesity and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for obesity

181. Modifying Alcohol Consumption to Reduce Obesity (MACRO): development and feasibility trial of a complex community-based intervention for men

Modifying Alcohol Consumption to Reduce Obesity (MACRO): development and feasibility trial of a complex community-based intervention for men Modifying Alcohol Consumption to Reduce Obesity (MACRO): development and feasibility trial of a complex community-based intervention for men Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from (...) the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} This study developed a novel intervention for reducing alcohol consumption in obese men and demonstrated the feasibility of a definitive trial. {{author}} {{($index , , , , , , , , , , , , & . Iain K Crombie, 1 ,* Kathryn B Cunningham, 1 Linda Irvine, 1 Brian Williams, 2 ,3 Falko F Sniehotta, 4 John Norrie, 5 ,6 Ambrose Melson, 1 ,7

NIHR HTA programme2017

182. Enzymatic hydrolysate from velvet antler suppresses adipogenesis in 3T3-L1 cells and attenuates obesity in high-fat diet-fed mice

Enzymatic hydrolysate from velvet antler suppresses adipogenesis in 3T3-L1 cells and attenuates obesity in high-fat diet-fed mice 28507477 2018 11 13 1611-2156 16 2017 EXCLI journal EXCLI J Enzymatic hydrolysate from velvet antler suppresses adipogenesis in 3T3-L1 cells and attenuates obesity in high-fat diet-fed mice. 328-339 10.17179/excli2016-638 The purpose of the current study was to investigate the potential anti-obesity activity of an enzymatic hydrolysate of velvet antler in inhibiting (...) adipogenesis in 3T3-L1 cells and in high-fat diet (HFD)-fed obese mice. The enzymatic hydrolysate was prepared using the commercial food grade protease, Protamex. The velvet antler Protamex hydrolysate (VAPH) indicated profound inhibitory effects on adipogenesis dose-dependently by decreasing the accumulation of triglycerides and down-regulating expression levels of adipogenesis-related proteins C/EBPα, SREBP-1, and PPARγ. In a mouse model of HFD-induced obesity, oral administration of VAPH (100 and 300 mg

EXCLI journal2017 Full Text: Link to full Text with Trip Pro

183. Beneficial Outcomes of Sleeve Gastrectomy in a Morbidly Obese Patient With Bardet-Biedl Syndrome

Beneficial Outcomes of Sleeve Gastrectomy in a Morbidly Obese Patient With Bardet-Biedl Syndrome 29264490 2018 11 13 2472-1972 1 4 2017 Apr 01 Journal of the Endocrine Society J Endocr Soc Beneficial Outcomes of Sleeve Gastrectomy in a Morbidly Obese Patient With Bardet-Biedl Syndrome. 317-322 10.1210/js.2017-00071 Severe obesity is one of the major features of Bardet-Biedl syndrome (BBS) and causes reduced life expectancy. Bariatric surgery is an effective treatment of morbid obesity. Data (...) on the effect of bariatric surgery for monogenic obesity is essentially lacking. We present the clinical and metabolic 3-year follow-up of sleeve gastrectomy in a BBS patient. A 37-year-old obese woman with BBS (body mass index, 40 kg/m 2 ) was referred to our clinic for uncontrolled diabetes, dyslipidemia, hypertension, and nonalcoholic fatty liver disease (NAFLD). After sleeve gastrectomy, progressive weight loss was observed, with a 32% total weight loss at 3-year follow-up. Glycemic control and NAFLD

Journal of the Endocrine Society2017 Full Text: Link to full Text with Trip Pro

184. Effect of Testosterone Treatment on Adipokines and Gut Hormones in Obese Men on a Hypocaloric Diet

Effect of Testosterone Treatment on Adipokines and Gut Hormones in Obese Men on a Hypocaloric Diet 29264488 2018 11 13 2472-1972 1 4 2017 Apr 01 Journal of the Endocrine Society J Endocr Soc Effect of Testosterone Treatment on Adipokines and Gut Hormones in Obese Men on a Hypocaloric Diet. 302-312 10.1210/js.2017-00062 In obese men with lowered testosterone levels, testosterone treatment augments diet-associated loss of body fat. We hypothesized that testosterone treatment modulates circulating (...) concentrations of hormonal mediators of fat mass and energy homeostasis in obese men undergoing a weight loss program. Prespecified secondary analysis of a randomized, double-blind, placebo-controlled trial. Tertiary referral center. Obese men (body mass index ≥30 kg/m 2 ) with a repeated total testosterone level ≤12 nmol/L. One hundred participants mean age 53 years (interquartile range 47 to 60 years) receiving 10 weeks of a very low-energy diet followed by 46 weeks of weight maintenance were randomly

Journal of the Endocrine Society2017 Full Text: Link to full Text with Trip Pro

185. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child.

Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. Obesity is the most common medical condition in women of reproductive age. Obesity during pregnancy has short term and long term adverse consequences for both mother and child. Obesity causes problems with infertility, and in early gestation it causes spontaneous pregnancy loss and congenital anomalies. Metabolically, obese women have increased insulin resistance in early pregnancy, which (...) becomes manifest clinically in late gestation as glucose intolerance and fetal overgrowth. At term, the risk of cesarean delivery and wound complications is increased. Postpartum, obese women have an increased risk of venous thromboembolism, depression, and difficulty with breast feeding. Because 50-60% of overweight or obese women gain more than recommended by Institute of Medicine gestational weight guidelines, postpartum weight retention increases future cardiometabolic risks and prepregnancy

BMJ2017

186. The Relationship of Obesity to Hospice Use and Expenditures: A Cohort Study.

The Relationship of Obesity to Hospice Use and Expenditures: A Cohort Study. Background: Obesity complicates medical, nursing, and informal care in severe illness, but its effect on hospice use and Medicare expenditures is unknown. Objective: To describe the associations between body mass index (BMI) and hospice use and Medicare expenditures in the last 6 months of life. Design: Retrospective cohort. Setting: The HRS (Health and Retirement Study). Participants: 5677 community-dwelling Medicare (...) obese decedents (BMI ≥40 kg/m2), the predicted probability of hospice enrollment decreased by 15.2 percentage points (CI, -19.6 to -10.9 percentage points), hospice duration decreased by 4.3 days (CI, -5.7 to -2.9 days), and in-home death decreased by 6.3 percentage points (CI, -11.2 to -1.5 percentage points) versus decedents with BMI of 20 kg/m2. Limitation: Baseline data were self-reported, and the interval between reported BMI and time of death varied. Conclusion: Among community-dwelling

Annals of Internal Medicine2017 Full Text: Link to full Text with Trip Pro

187. Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years

Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years Randomised controlled trial evaluating the effectiveness (...) and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years Robertson W, Fleming J, Kamal A, Hamborg T, Khan K A, Griffiths F, Stewart-Brown S, Stallard N, Petrou S, Simkiss D, Harrison E, Kim S W & Thorogood M Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA

Health Technology Assessment (HTA) Database.2017

188. The Obesity Paradox in Kidney Disease: How to Reconcile It With Obesity Management

The Obesity Paradox in Kidney Disease: How to Reconcile It With Obesity Management 28439569 2018 11 13 2468-0249 2 2 2017 Mar Kidney international reports Kidney Int Rep The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management. 271-281 10.1016/j.ekir.2017.01.009 Obesity, a risk factor for de novo chronic kidney disease (CKD), confers survival advantages in advanced CKD. This so-called obesity paradox is the archetype of the reverse epidemiology of cardiovascular risks (...) , in addition to the lipid, blood pressure, adiponectin, homocysteine, and uric acid paradoxes. These paradoxical phenomena are in sharp contradistinction to the known epidemiology of cardiovascular risks in the general population. In addition to advanced CKD, the obesity paradox has also been observed in heart failure, chronic obstructive lung disease, liver cirrhosis, and metastatic cancer, as well as in the elderly. These are populations in whom protein-energy wasting and inflammation are strong

Kidney international reports2017 Full Text: Link to full Text with Trip Pro

189. Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux

Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux 28243403 2018 11 13 2008-5842 9 1 2017 Jan Electronic physician Electron Physician Laparoscopic Sleeve Gastrectomy and Crural Repair as a Treatment of Morbid Obesity Associated with Gastroesophageal Reflux. 3529-3534 10.19082/3529 The aim of this study was to evaluate the Laparoscopic Sleeve Gastrectomy (LSG) with simultaneous crural repair in treatment of morbid obesity (...) associated with gastroesophageal reflux disease. This prospective observational study was carried out from September 2012 to July 2016 in Al-Azhar University Hospital (Egypt). The study was conducted on 53 patients, 14 males (26.4%) and 39 females (73.6%) with the mean age 36.2 years (range 18-52 years), presenting with morbid obesity and reflux disease either symptomatic patients or asymptomatic (Endoscopic & Manometric), their mean Body Mass Index (BMI) was 50.1 kg/m 2 (range 40-62 kg/m 2 ), who

Electronic physician2017 Full Text: Link to full Text with Trip Pro

190. Comparing methods of targeting obesity interventions in populations: An agent-based simulation

Comparing methods of targeting obesity interventions in populations: An agent-based simulation 29349218 2018 11 13 2352-8273 3 2017 Dec SSM - population health SSM Popul Health Comparing methods of targeting obesity interventions in populations: An agent-based simulation. 211-218 10.1016/j.ssmph.2017.01.006 Social networks as well as neighborhood environments have been shown to effect obesity-related behaviors including energy intake and physical activity. Accordingly, harnessing social (...) networks to improve targeting of obesity interventions may be promising to the extent this leads to social multiplier effects and wider diffusion of intervention impact on populations. However, the literature evaluating network-based interventions has been inconsistent. Computational methods like agent-based models (ABM) provide researchers with tools to experiment in a simulated environment. We develop an ABM to compare conventional targeting methods (random selection, based on individual obesity risk

SSM - population health2017 Full Text: Link to full Text with Trip Pro

191. The Renal Pathology of Obesity

The Renal Pathology of Obesity 29142961 2018 11 13 2468-0249 2 2 2017 Mar Kidney international reports Kidney Int Rep The Renal Pathology of Obesity. 251-260 10.1016/j.ekir.2017.01.007 Obesity causes various structural, hemodynamic, and metabolic alterations in the kidney. Most of these are likely to be compensatory responses to the systemic increase in metabolic demand that is seen with obesity. In some cases, however, renal injury becomes clinically apparent as a result of compensatory (...) failure. Obesity-related glomerulopathy is the best known of such disease states. Factors that may sensitize obese individuals to renal compensatory failure and associated injury include the severity and number of obesity-associated conditions or complications, including components of metabolic syndrome, and the mismatch of body size to nephron mass, due to nephron reductions of congenital or acquired origin. Tsuboi Nobuo N Division of Nephrology and Hypertension, Department of Internal Medicine

Kidney international reports2017 Full Text: Link to full Text with Trip Pro

192. Preconception consultations with Maternal Fetal Medicine for obese women: a retrospective chart review

Preconception consultations with Maternal Fetal Medicine for obese women: a retrospective chart review 28620542 2018 11 13 2054-7099 3 2017 Fertility research and practice Fertil Res Pract Preconception consultations with Maternal Fetal Medicine for obese women: a retrospective chart review. 3 10.1186/s40738-016-0030-9 Obesity is associated with impaired fertility and pregnancy complications, and preconception weight loss may improve some of these outcomes. The purpose of this study (...) was to evaluate the quality and effectiveness of Maternal Fetal Medicine (MFM) preconception consults for obese women. We performed a retrospective chart review examining 162 consults at an academic medical center from 2008 to 2014. The main outcome measures included consultation content - e.g. discussion of obesity-related pregnancy complications, screening for comorbidities, and referrals for weight loss interventions - and weight loss. Screening for diabetes and hypertension occurred in 48% and 51

Fertility research and practice2017 Full Text: Link to full Text with Trip Pro

193. Obesity, cigarette smoking, and telomere length in women.

Obesity, cigarette smoking, and telomere length in women. Obesity and smoking are important risk factors for many age-related diseases. Both are states of heightened oxidative stress, which increases the rate of telomere erosion per replication, and inflammation, which enhances white blood cell turnover. Together, these processes might accelerate telomere erosion with age. We therefore tested the hypothesis that increased body mass and smoking are associated with shortened telomere length (...) in white blood cells. We investigated 1122 white women aged 18-76 years and found that telomere length decreased steadily with age at a mean rate of 27 bp per year. Telomeres of obese women were 240 bp shorter than those of lean women (p=0.026). A dose-dependent relation with smoking was recorded (p=0.017), and each pack-year smoked was equivalent to an additional 5 bp of telomere length lost (18%) compared with the rate in the overall cohort. Our results emphasise the pro-ageing effects of obesity and cigarette

Lancet2017

194. Physical activity, obesity, height, and the risk of pancreatic cancer.

Physical activity, obesity, height, and the risk of pancreatic cancer. CONTEXT: Diabetes mellitus and elevated postload plasma glucose levels have been associated with an increased risk of pancreatic cancer in previous studies. By virtue of their influence on insulin resistance, obesity and physical inactivity may increase risk of pancreatic cancer. OBJECTIVE: To examine obesity, height, and physical activity in relation to pancreatic cancer risk. DESIGN AND SETTING: Two US cohort studies (...) (multivariable RR, 0.45; 95% CI, 0.29-0.70 for the highest vs lowest categories; P for trend <.001). Total physical activity was not associated with risk among individuals with a BMI of less than 25 kg/m(2) but was inversely associated with risk among individuals with a BMI of at least 25 kg/m(2) (pooled multivariable RR, 0.59; 95% CI, 0.37-0.94 for the top vs bottom tertiles of total physical activity; P for trend =.04). CONCLUSION: In 2 prospective cohort studies, obesity significantly increased

JAMA2017

195. Platelet activation in obese women: role of inflammation and oxidant stress.

Platelet activation in obese women: role of inflammation and oxidant stress. CONTEXT: Obesity, in particular abdominal adiposity, is associated with increased cardiovascular morbidity and mortality through mechanisms possibly linking the metabolic disorder to platelet and vascular abnormalities. OBJECTIVE: To investigate the clinical and biochemical determinants of lipid peroxidation and platelet activation in obese women. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional comparison, conducted (...) between September 1999 and September 2001, of urinary 8-iso prostaglandin F(2alpha) (8-iso PGF(2alpha)) and 11-dehydrothromboxane B2 (11-dehyhdro-TxB2) excretion levels in 93 women: 44 with a body mass index (BMI) higher than 28 and a waist-to-hip ratio (WHR) of 0.86 or higher, android obesity; 25 with a BMI higher than 28 and a WHR lower than 0.86, gynoid obesity; and 24 nonobese women with a BMI lower than 25. An additional study was conducted to determine the short-term effects of weight loss in 20

JAMA2017

196. Obesity in Adolescents

Obesity in Adolescents Obesity in Adolescents - ACOG Menu ▼ Obesity in Adolescents Page Navigation ▼ Number 714, September 2017 Committee on Adolescent Health Care This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care in collaboration with committee members Bliss Kaneshiro, MD, MPH and Samantha Erin Vilano, MD, MSc. This information is designed as an educational resource to aid clinicians in providing obstetric (...) , warrant, or endorse the products or services of any firm, organization, or person. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented. Obesity in Adolescents ABSTRACT: Rates of obesity among adolescents in the United States have increased at a dramatic rate

American College of Obstetricians and Gynecologists2017

197. Pediatric Obesity: Assessment, Treatment, and Prevention

Pediatric Obesity: Assessment, Treatment, and Prevention '); '); Pediatric Obesity Guideline Resources | Endocrine Society Hormone Science to Health / › › › Guidelines and Clinical Practice Section + Pediatric Obesity Guideline Resources Full Guideline: JCEM | January 2017 Dennis M. Styne (chair), Silva A. Arslanian, Ellen L. Connor, Ismaa Sadaf Farooqi, M. Hassan Murad, Janet H. Silverstein, and Jack A. Yanovski The Endocrine Society's 2017 guideline is an update of the previous version from (...) 2008. This guideline addresses: Preventing and treating childhood obesity with lifestyle changes Evaluating affected children for medical or psychological complications Deciding when to evaluate children for rare genetic causes of obesity Determining when medication or surgery is appropriate for severely affected adolescents Resources | Endocrine News | Endocrine Society | ENDO 2016 | Guideline Central | Hormone Health Network | Endocrine Society Pediatric Obesity - Assessment, Treatment

The Endocrine Society2017

198. Obesity in Children and Adolescents: Screening

Obesity in Children and Adolescents: Screening Final Recommendation Statement: Obesity in Children and Adolescents: Screening - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 3/6/2018 4:20:40 PM You are here: Final Recommendation Statement : Final Recommendation Statement Final Recommendation Statement Obesity in Children and Adolescents: Screening Recommendations made by the USPSTF are independent of the U.S. government. They should (...) not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. Recommendation Summary Population Recommendation Grade Children and adolescents 6 years and older The USPSTF recommends that clinicians screen for obesity in children and adolescents 6 years and older and offer or refer them to comprehensive, intensive behavioral interventions to promote improvements in weight status. To read the recommendation statement in JAMA

U.S. Preventive Services Task Force2017

199. Obesity and Metabolism

Obesity and Metabolism AMERICANTHORACICSOCIETY DOCUMENTS AnOf?cialAmericanThoracicSocietyWorkshopReport:Obesity andMetabolism An Emerging Frontier in Lung Health and Disease Benjamin T. Suratt, Niki D. J. Ubags, Deepa Rastogi, Kelan G. Tantisira, Benjamin J. Marsland, Irina Petrache, JaniceB.Allen,JasonH.T.Bates,FernandoHolguin,MeredithC.McCormack,EvangelosD.Michelakis,StephenM.Black, ManuJain,AnaL.Mora,ViswanathanNatarajan,YuryI.Miller, MichaelB.Fessler,KonstantinG.Birukov,RossS.Summer (...) Copyright© 2017 by the American Thoracic Society DOI: 10.1513/AnnalsATS.201703-263WS Internet address: www.atsjournals.org Contents Methods Obesity of Airway Diseases Insights Derived from Omics Approaches Insights Derived from Other Approaches Mitochondrial and Cellular Metabolism in Lung Disease Pulmonary Circulation Fibrotic Remodeling LipidHandlingandMishandling:Lung In?ammation and Remodeling Conclusions Obesity is a complex disorder characterized bychangesindietaryintake,physicalactivity

American Thoracic Society2017

200. Final recommendation statement: obesity in children and adolescents: screening.

Final recommendation statement: obesity in children and adolescents: screening. Final recommendation statement: obesity in children and adolescents: screening. | National Guideline Clearinghouse success fail JUN 09 2017 2018 2019 14 Apr 2018 - 12 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history (...) at . TIMESTAMPS Search Sign In Username or Email * Password * Remember Me Don't have an account? The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018 because federal funding through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our . Guideline Summary NGC:011239 2017 Jun NEATS Assessment Final recommendation statement: obesity in children and adolescents: screening. Final recommendation

National Guideline Clearinghouse (partial archive)2017